Sunitinib Malate in Treating Patients With Recurrent Transitional Cell Bladder Cancer

Clinical trial NCT01118351 · TERMINATED

Trial details

NCT number: NCT01118351
Sponsor: Case Comprehensive Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Bladder Cancer Transitional Cell Carcinoma of the Bladder

Start date: 2008-10-01
Primary completion: 2012-07-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.